Skip to main content
Premium Trial:

Request an Annual Quote

Whitehead Scans Liver and Pancreas Genomes for Diabetes Clues

NEW YORK, Feb. 27 (GenomeWeb News) - Scientists from the Whitehead Institute for Biomedical Research have published a study in today's issue of Science, in which they describe a method for scanning the genomes of human liver and pancreas in order to map the location of gene regulators that are known to be involved in type 2 diabetes.

 

The genome scanning technology is a modified version of a technology used to identify the role of transcription factors in the yeast genome, first reported in Science in October 2002. This is the first time the technology has been applied to human organs, according to Whitehead.

 

The team of scientists, led by Richard Young - who developed the original technology - found that one transcription factor, HNF4, controls about half of the genes involved in developing the pancreas and liver. The gene is thought to be involved in type 2 diabetes.

 

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.